| Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 S Neumann-Böhme, NE Varghese, I Sabat, PP Barros, W Brouwer, ... The European Journal of Health Economics 21 (7), 977, 2020 | 1272 | 2020 |
| Economic valuation of informal care B Van den Berg, WBF Brouwer, MA Koopmanschap The European Journal of Health Economics, formerly: HEPAC 5 (1), 36-45, 2004 | 601 | 2004 |
| Welfarism vs. extra-welfarism WBF Brouwer, AJ Culyer, NJA van Exel, FFH Rutten Journal of health economics 27 (2), 325-338, 2008 | 550 | 2008 |
| The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses C Bouwmans, M Krol, H Severens, M Koopmanschap, W Brouwer, ... Value in health 18 (6), 753-758, 2015 | 537 | 2015 |
| The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations WBF Brouwer, NJA Van Exel, B Van Gorp, WK Redekop Quality of Life Research 15 (6), 1005-1021, 2006 | 485 | 2006 |
| Discounting in economic evaluations AE Attema, WBF Brouwer, K Claxton Pharmacoeconomics 36 (7), 745-758, 2018 | 431 | 2018 |
| Lifetime medical costs of obesity: prevention no cure for increasing health expenditure PHM van Baal, JJ Polder, GA De Wit, RT Hoogenveen, TL Feenstra, ... PLoS medicine 5 (2), e29, 2008 | 373 | 2008 |
| An overview of methods and applications to value informal care in economic evaluations of healthcare MA Koopmanschap, NJA van Exel, B van den Berg, WBF Brouwer Pharmacoeconomics 26 (4), 269-280, 2008 | 334 | 2008 |
| Productivity losses without absence: measurement validation and empirical evidence WBF Brouwer, MA Koopmanschap, FFH Rutten Health policy 48 (1), 13-27, 1999 | 325 | 1999 |
| Caring for and caring about: disentangling the caregiver effect and the family effect A Bobinac, NJA Van Exel, FFH Rutten, WBF Brouwer Journal of health economics 29 (4), 549-556, 2010 | 313 | 2010 |
| Productivity costs in economic evaluations: past, present, future M Krol, W Brouwer, F Rutten Pharmacoeconomics 31 (7), 537-549, 2013 | 306 | 2013 |
| Need for differential discounting of costs and health effects in cost effectiveness analyses WBF Brouwer, LW Niessen, MJ Postma, FFH Rutten Bmj 331 (7514), 446-448, 2005 | 292 | 2005 |
| Costing in economic evaluations W Brouwer, F Rutten, M Koopmanschap Economic evaluation in health care: merging theory with practice 2, 68-93, 2001 | 291 | 2001 |
| Process utility from providing informal care: the benefit of caring WBF Brouwer, NJA van Exel, B van den Berg, GAM van den Bos, ... Health policy 74 (1), 85-99, 2005 | 287 | 2005 |
| United but divided: Policy responses and people’s perceptions in the EU during the COVID-19 outbreak I Sabat, S Neumann-Böhme, NE Varghese, PP Barros, W Brouwer, ... Health Policy 124 (9), 909-918, 2020 | 283 | 2020 |
| Discounting and decision making in the economic evaluation of health‐care technologies K Claxton, M Paulden, H Gravelle, W Brouwer, AJ Culyer Health economics 20 (1), 2-15, 2011 | 281 | 2011 |
| How to estimate productivity costs in economic evaluations M Krol, W Brouwer Pharmacoeconomics 32 (4), 335-344, 2014 | 280 | 2014 |
| Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel WBF Brouwer, MA Koopmanschap, FFH Rutten Health Economics 6 (3), 253-259, 1997 | 275 | 1997 |
| Quality of life instruments for economic evaluations in health and social care for older people: a systematic review P Makai, WBF Brouwer, MA Koopmanschap, EA Stolk, AP Nieboer Social science & medicine 102, 83-93, 2014 | 272 | 2014 |
| Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods B Van den Berg, W Brouwer, J van Exel, M Koopmanschap, ... Social science & medicine 62 (4), 835-845, 2006 | 263 | 2006 |
Job van ExelErasmus University RotterdamVerified email at eshpm.eur.nl
